We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+6.72%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$616B
AUM Growth
+$31B
Cap. Flow
-$1.19B
Cap. Flow %
-0.19%
Top 10 Hldgs %
18.88%
Holding
2,692
New
121
Increased
947
Reduced
1,282
Closed
130

Top Buys

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$1.86B
2
VMW
VMware, Inc
VMW
+$1.49B
3
AVGO icon
Broadcom
AVGO
+$1.29B
4
SRE icon
Sempra
SRE
+$1.26B
5
BKNG icon
Booking.com
BKNG
+$1.12B

Sector Composition

Rank Sector Weight
1 Healthcare 17.07%
2 Financials 16.19%
3 Technology 16.15%
4 Consumer Discretionary 13.93%
5 Industrials 9.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NOW icon
51
ServiceNow
NOW
$132B
$2.54B 0.41%
97,307,900
+988,980
+1% +$24.6M
FIS icon
52
Fidelity National Information Services
FIS
$21.9B
$2.53B 0.41%
26,935,536
+582,826
+2% +$54.8M
CB icon
53
Chubb
CB
$134B
$2.53B 0.41%
17,336,288
+5,476,652
+46% +$818M
ALXN
54
DELISTED
Alexion Pharmaceuticals
ALXN
$2.51B 0.41%
21,006,788
-1,274,860
-6% -$155M
EA
55
DELISTED
Electronic Arts
EA
$2.48B 0.4%
23,647,086
-618,873
-3% -$68.8M
WDAY icon
56
Workday
WDAY
$45.5B
$2.47B 0.4%
24,253,774
+6,866,749
+39% +$733M
WTW icon
57
Willis Towers Watson
WTW
$31.9B
$2.39B 0.39%
15,882,322
+3,729,190
+31% +$589M
MAR icon
58
Marriott International
MAR
$90.9B
$2.34B 0.38%
17,270,143
-1,063,926
-6% -$131M
TMO icon
59
Thermo Fisher Scientific
TMO
$222B
$2.29B 0.37%
12,077,960
-254,187
-2% -$48.7M
DD icon
60
DuPont de Nemours
DD
$19.1B
$2.27B 0.37%
12,571,080
+753,050
+6% +$136M
PFE icon
61
Pfizer
PFE
$154B
$2.25B 0.36%
65,349,342
-157,381
-0.2% -$5.37M
FITB
62
Fifth Third Bancorp
FITB
$51.8B
$2.23B 0.36%
73,452,323
+2,022,616
+3% +$59M
GEN icon
63
Gen Digital
GEN
$17.5B
$2.21B 0.36%
78,792,626
+9,312,648
+13% +$279M
QCOM icon
64
Qualcomm
QCOM
$170B
$2.19B 0.36%
34,225,212
-1,978,123
-5% -$120M
CSCO icon
65
Cisco
CSCO
$483B
$2.19B 0.35%
57,062,275
+1,248,169
+2% +$44.6M
WCN
66
Waste Connections
WCN
$41.8B
$2.17B 0.35%
30,655,456
+569,498
+2% +$39.8M
HD icon
67
Home Depot
HD
$350B
$2.13B 0.35%
11,244,422
-2,697,583
-19% -$466M
AMT icon
68
American Tower
AMT
$78.8B
$2.13B 0.35%
14,905,545
-6,520,696
-30% -$931M
CMCSA icon
69
Comcast
CMCSA
$89.4B
$2.07B 0.34%
51,809,728
-15,446,348
-23% -$581M
LHX icon
70
L3Harris
LHX
$54B
$2.06B 0.33%
14,548,924
+265,683
+2% +$37.1M
MDT icon
71
Medtronic
MDT
$114B
$1.96B 0.32%
24,229,161
-788,884
-3% -$63.2M
NEE icon
72
NextEra Energy
NEE
$177B
$1.95B 0.32%
50,023,512
+246,752
+0.5% +$9.53M
HOLX
73
DELISTED
Hologic
HOLX
$1.93B 0.31%
45,202,039
+1,195,214
+3% +$47.7M
WMT icon
74
Walmart Inc
WMT
$897B
$1.92B 0.31%
58,354,524
-148,545
-0.3% -$4.54M
TXT icon
75
Textron
TXT
$15.3B
$1.92B 0.31%
33,927,683
+373,535
+1% +$20.3M

Similar funds

T. Rowe Price Associates's Q4 2017 Portfolio in Review

As of Q4 2017, T. Rowe Price Associates held 2,692 positions worth $616B, up 5.3% from $585B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

T. Rowe Price Associates's Q4 2017 filing shows 121 new, 947 increased, 1,282 reduced and 130 closed positions. Its largest new stake was CarGurus: 13,060,603 shares worth $374M. The largest sale was PayPal, an estimated $1.66B.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, down from 18% a quarter earlier, followed by Financials and Technology.

  • T. Rowe Price Associates's largest Q4 2017 buy was CarGurus: 13,060,603 shares worth $374M.
  • T. Rowe Price Associates added most to Tesla in Q4 2017, an estimated $1.86B increase.
  • T. Rowe Price Associates's biggest Q4 2017 reduction was PayPal, cutting an estimated $1.66B.
  • T. Rowe Price Associates fully exited Kite Pharma, Inc. in Q4 2017, selling an estimated $483M.
  • T. Rowe Price Associates's ten largest holdings make up 19% of its $616B portfolio in Q4 2017.
  • T. Rowe Price Associates opened 121 new positions and closed 130 in Q4 2017.
  • T. Rowe Price Associates's portfolio value rose 5.3% quarter-over-quarter to $616B.

Based on T. Rowe Price Associates's 13F filing for Q4 2017, filed 14 Feb 2018.